The Board of Directors of Kanoria Chemicals & Industries Limited, at its meeting held on 25th May 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2026. The company reported a standalone revenue from operations of Rs. 267.34 Crores for the quarter ended 31st March 2026, compared to Rs. 230.59 Crores in the preceding quarter (December 2025) and Rs. 193.29 Crores in the corresponding quarter of the previous year (March 2025). The net profit for the current quarter stood at Rs. 3.55 Crores, representing a significant turnaround from the net loss of Rs. 4.22 Crores reported in the quarter ended 31st December 2025 and a recovery from the net loss of Rs. 36.18 Crores reported in the quarter ended 31st March 2025.

Kanoria Chemicals & Industries Limited, part of the S. S. Kanoria Group, is a leading Indian manufacturer of chemical intermediates and specialties, with a diversified presence in automotive electronics and textiles. Guided by its “Vision-2030” strategy, the company has been focusing on product diversification—incorporating products like Triacetin and EGDA—and capacity expansions, such as the commissioning of a 345 TPD Formaldehyde plant in September 2024 to strengthen its market position. A notable investor in the company is R. V. Investment and Dealers Limited, which holds approximately 7.35% of the company’s equity.